Teladoc Health Inc. (TDOC)
NYSE
6.20
-0.19 (-2.97%)
Closed
Aug 24, 2026
Day's Range
6.176.40
52 wk Range
4.409.89
Financial Statements - TDOC - Teladoc Health Inc.
Revenue
2.52B▼ 1.5%
Net Income
-200.32M▲ 80.0%Net Margin -7.9%
EBITDA
260.17M▲ 15.6%
Free Cash Flow
137.33M▼ 19.0%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 2.52B | 2.56B | 2.60B | 2.40B | 2.03B | 1.09B |
| Cost of Goods | 771.59M | 751.27M | 760.03M | 743.98M | 650.25M | 390.82M |
| Gross Profit | 1.75B | 1.81B | 1.84B | 1.66B | 1.38B | 703.13M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -163.39M | -208.78M | -210.50M | -227.36M | -238.98M | -418.18M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | -89.18M | -818.13M | -33.60M | -13.42B | -65.30M | -97.85M |
| Pre Tax Income | -235.53M | -993.65M | -219.60M | -13.66B | -384.65M | -575.99M |
| Income Tax | -35.20M | 7.59M | 760K | -3.81M | 44.13M | -90.85M |
| Net Income | -200.32M | -1B | -220.36M | -13.65B | -428.79M | -485.13M |
| EPS Basic | -1.14 | -5.87 | -1.34 | -84.6 | -2.73 | -5.36 |
| EPS Diluted | -1.14 | -5.87 | -1.34 | -84.6 | -2.73 | -5.36 |
| Basic Shares Outstanding | 176.22M | 170.56M | 162.16M | 161.45M | 156.93M | 90.50M |
| Diluted Shares Outstanding | 176.22M | 170.56M | 162.16M | 161.45M | 156.93M | 90.50M |
| Ebit | -215.81M | -969.85M | -197.32M | -13.64B | -303.51M | -516.04M |
| Ebitda | 260.17M | 225.09M | 192.04M | 55.09M | -13.50M | -340.64M |
| Net Income Continuous Operations | -200.32M | -1B | -220.36M | -13.65B | -428.79M | -485.13M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
